Christian Spath

Ferdinand Sauerbruch Str
Greifswald, MV 17475, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Donor-Derived Clonal Haematopoiesis after Allogeneic Stem-Cell Transplantation: A Case Report.

Donor-Derived Clonal Haematopoiesis after Allogeneic Stem-Cell Transplantation: A Case Report.

Journal: Acta haematologica

Published: March 27, 2025

Antileukaemic rescue by dose-dense donor-lymphocyte infusions in T-PLL after allogeneic stem cell transplantation - a case report.

Antileukaemic rescue by dose-dense donor-lymphocyte infusions in T-PLL after allogeneic stem cell transplantation - a case report.

Journal: Annals of hematology

Published: March 24, 2024

Patients receiving allogeneic haematopoietic stem-cell transplantation and clinical outcomes after early access to palliative care.

Patients receiving allogeneic haematopoietic stem-cell transplantation and clinical outcomes after early access to palliative care.

Journal: The Lancet. Haematology

Published: December 02, 2022

Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.

Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.

Journal: Annals of hematology

Published: October 12, 2022

Rhabdomyolysis induced by nelarabine.

Rhabdomyolysis induced by nelarabine.

Journal: Annals of hematology

Published: May 23, 2022

Correction to: Allogeneic hematopoietic stem cell transplantation improves long‑term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.

Correction to: Allogeneic hematopoietic stem cell transplantation improves long‑term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.

Journal: Annals of hematology

Published: September 16, 2021

Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.

Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.

Journal: Annals of hematology

Published: November 10, 2020

Allogeneic stem cell transplantation in patients above 55: suggestion for a further stratification of the HCT-CI.

Allogeneic stem cell transplantation in patients above 55: suggestion for a further stratification of the HCT-CI.

Journal: Journal of cancer research and clinical oncology

Published: May 08, 2014

Long-term follow-up of high-dose chemotherapy with autologous stem-cell transplantation and response-adapted whole-brain radiotherapy for newly diagnosed primary CNS lymphoma: results of the multicenter Ostdeutsche Studiengruppe Hamatologie und Onkologie OSHO-53 phase II study.

Long-term follow-up of high-dose chemotherapy with autologous stem-cell transplantation and response-adapted whole-brain radiotherapy for newly diagnosed primary CNS lymphoma: results of the multicenter Ostdeutsche Studiengruppe Hamatologie und Onkologie OSHO-53 phase II study.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 26, 2011

Showing 1-9 of 9

Last Updated: 09/26/2026